Alzheimer's Disease Research

Alzheimer's disease (AD), the most common type of dementia, is an irreversible and progressive neurodegenerative disorder causing cognitive and functional impairment. It is characterized by formation of protein aggregates and progressive loss of neurons in the central nervous system (CNS). The symptoms of AD include short-term memory loss, confusion, irritability, aggression and mood swings, progressing to long-term memory deficit, withdrawal from social interactions and subsequently a loss in higher central functioning.

Alzheimer's Disease Research Products Targets

Products for Alzheimer's Disease Research - Page 22

  1. Cat.No. Product Name Information/Activity
  2. BCC6585 2,4-Dihydroxyphenylacetyl-L-asparagine 111872-98-1 2,4-Dihydroxyphenylacetyl-L-asparagine chemical structure
  3. BCC5051 Lamotrigine Lamotrigine(BW430C) is a novel anticonvulsant drug for inhibition of 5-HT and sodium channel Target: Sodium Channel Lamotrigine stabilises presynaptic neuronal membranes by blockade of voltage-dependent sodium channels, thus preventing the release of excitatory neurotransmitters, particularly glutamate and aspartate [1]. Lamotrigine chemical structure
  4. BCC7086 MNI-caged-L-glutamate 295325-62-1 MNI-caged-L-glutamate chemical structure
  5. BCC7453 Pentylenetetrazole 54-95-5 Pentylenetetrazole chemical structure
  6. BCC6731 Salsolinol-1-carboxylic acid 57256-34-5 Salsolinol-1-carboxylic acid chemical structure
  7. BCC6632 Spaglumic acid Spaglumic Acid is a neuropeptide found in millimolar concentrations in brain. Spaglumic acid chemical structure
  8. BCN2571 L-Theanine L-Theanine (L-Glutamic Acid γ-ethyl amide)is a non-protein amino acid contained in green tea leaves, which blocks the binding of L-glutamic acid to glutamate receptors in the brain, and with neuroprotective and anti-oxidative activities. L-Theanine causes anti-stress effects via the inhibition of cortical neuron excitation by oral intake. L-Theanine chemical structure
  9. BCC2512 Zonisamide Zonisamide is a 1,2 benzisoxazole derivative and the first agent of this chemical class to be developed as an antiepileptic drug. Zonisamide chemical structure
  10. BCC7705 3-Bromocytisine 3-Bromocytisine (3-Br-cytisine) is a potent nACh receptors agonist, with IC50s are 0.28, 0.30 and 31.6 nM for hα4β4, hα4β2, and hα7-nACh, respectively. 3-Bromocytisine (3-Br-cytisine) shows different effects on high (HS) and low (LS) ACh sensitivity α4β2 nAChRs with EC50s are 8 and 50 nM, respectively. 3-Bromocytisine chemical structure
  11. BCC7099 5-Iodo-A-85380 dihydrochloride 1217837-17-6 5-Iodo-A-85380 dihydrochloride chemical structure

Items 211 to 220 of 399 total